Rebekah Jakel
| Years in MSTP | 1999-2007 |
| PhD | Neuroscience |
| Mentor | Jeffrey Johnson |
| Thesis | The Antioxidant Response Element and Dopaminergic Toxicity |
| Residency | Psychiatry, Duke University |
Publications
Johnson JA, Johnson DA, Kraft AD, Calkins MJ, Jakel RJ, Vargas MR, Chen PC. 2008. The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration (review). Ann NY Acad Sci 147:61-9. PMCID: 2605641
Lee JM, Li J, Johnson DA, Stein TD, Kraft AD, Calkins MJ, Jakel RJ, Johnson JA. 2005. Nrf2, a multi-organ protector? FASEB J 19:1061-66.
Jakel RJ, Townsend JA, Kraft AD, Johnson JA. 2007. Nrf2-mediated protection against 6-hydroxydopamine. Brain Res 114:192-201.
Jakel RJ, Kern JT, Johnson DA, Johnson JA. 2005. Induction of the protective antioxidant response element pathway by 6-hydroxydopamine in vivo and in vitro. Toxicol Sci 87:176-86.
Calkins MJ, Jakel RJ, Johnson DA, Chan K, Kan YW, Johnson JA. 2005. Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription. Proc Natl Acad Sci USA 102:244-9. PMCID: 538748
Jakel RJ, Schneider BL, Svendsen CN. 2004. Using human neural stem cells to model neurological disease (review). Nat Rev Genet 5:136-44.
McBride JL, Behrstock SP, Jakel RJ, Siegel I, Svendsen CN, Kordower JH. 2004. Human neural stem cell transplants improve motor function in a rat model of Huntington's disease. J Comp Neurol 475:211-19.